Skip to main content

Table 1 Clinicopathological characteristics of patient samples and expression of IQGAP3 in HCC

From: Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma

Clinical character

Variable

No. of patients (%)

Age (years)

≤50

53 (44.2)

>50

67 (55.8)

Gender

Female

13 (10.8)

Male

107 (89.2)

Clinical stage

I

48 (40.0)

II

44 (36.7)

III

21 (17.5)

IV

7 (5.8)

Cirrhosis

No

58 (48.3)

Yes

62 (51.7)

T classification

T1

53 (44.2)

T2

12 (10.0)

T3

6 (5.0)

T4

49 (40.8)

N classification

N0

97 (80.8)

N1

23 (19.2)

M classification

M0

113 (94.2)

M1

7 (5.8)

HCV

No

119 (99.2)

Yes

1 (0.8)

HBsAg

Negative

17 (14.2)

Positive

103 (85.8)

Vital status

Alive

17 (14.2)

Death

103 (85.8)

IQGAP3 expression

Low expression

68 (56.7)

High expression

52 (43.3)

  1. IQGAP3 IQ motif-containing GTPase activating protein 3